Reducing Routine Cardiology Evaluation Prior to Initiating Propranolol for Infantile Hemangiomas
Otolaryngology–Head and Neck Surgery · 2025
DOI: 10.1002/ohn.70014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2025. Verfasst von Eve P Champaloux und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head & Neck Surgery, University of Washington School of Medicine, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Propranolol, Hemangioma, Adrenergic beta-Antagonists, Skin Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
Objective
Determine if all patients with infantile hemangioma (IH) should undergo cardiology evaluation prior to initiating propranolol therapy or if only select patients should undergo cardiology evaluation, as indicated by a Propranolol Screening Checklist (PSC).
Methods
Retrospective review of 806 IH patients treated with propranolol between 2008 and 2018 at a single tertiary center. Statistical process control methods were used to compare the cardiology recommendations between the pre‐PSC and post‐PSC populations and there was special cause variation after implementation of the checklist.
Results
There were 527 (73.1%) patients referred for cardiology evaluation prior to propranolol initiation for IH before implementation of the PSC compared to 10 (11.5%) patients referred after PSC implementation ( P < .001). There was less testing obtained from patients prior to initiating therapy, like echocardiograms and EKGs. No patients were prevented from initiating therapy throughout the time studied.
Discussion
Cardiology referral prior to initiating propranolol therapy for IH is unnecessary in otherwise healthy infants without concerning signs or symptoms.
Implications for Practice
Propranolol therapy can be instituted safely in most IH patients after screening for the need for cardiology referral. This improves efficiency for families and institutions with high complexity patients. This may avoid the long wait times for specialist care which delays this time‐sensitive intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head & Neck Surgery, University of Washington School of Medicine, Seattle, Washington, USA.
- Otolaryngology Division, Alaska Native Tribal Health Consortium, Ancourage, Alaska, USA.
- Division of Pediatric Otolaryngology-Head & Neck Surgery, Seattle Children's Hospital, Seattle, Washington, USA.
- Department of Pediatrics, University School of Medicine, Division of Cardiology, Seattle Children's Hospital, Seattle, Washington, USA.
- Biostatistics Epidemiology and Analytics for Research (BEAR) Core, Seattle Children's Hospital, Seattle, Washington, USA.
- Department of Dermatology, University of Washington Medical School, Seattle, Washington, USA.
ORCID-Profile: Eve P Champaloux
Zitieren
APA
Champaloux, E. P., Epstein, S., Bull, C., Vernon, M. M., Meyer, S., Lutsky, E., Wang, X., Ganti, S., Gupta, D., Perkins, J. A., & Dahl, J. P. (2025). Reducing Routine Cardiology Evaluation Prior to Initiating Propranolol for Infantile Hemangiomas. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.70014
Vancouver
Champaloux EP, Epstein S, Bull C, Vernon MM, Meyer S, Lutsky E, et al. Reducing Routine Cardiology Evaluation Prior to Initiating Propranolol for Infantile Hemangiomas. Otolaryngology–Head and Neck Surgery. 2025. doi:10.1002/ohn.70014
BibTeX
@article{Champaloux2025,
author = {Champaloux, Eve P and Epstein, Sherise and Bull, Catherine and Vernon, Margaret M and Meyer, Shannon and Lutsky, Erika and Wang, Xing and Ganti, Sheila and Gupta, Deepti and Perkins, Jonathan A and Dahl, John P},
title = {Reducing Routine Cardiology Evaluation Prior to Initiating Propranolol for Infantile Hemangiomas},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2025},
doi = {10.1002/ohn.70014}
}
EUVIMED